UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The lancet oncology, ISSN 1470-2045, 2016, Volume 17, Issue 12, pp. 1672 - 1682
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - drug therapy | Lung Neoplasms - mortality | Humans | Middle Aged | Lung Neoplasms - pathology | Male | Carcinoma, Non-Small-Cell Lung - mortality | Neoplasm Metastasis | Aged, 80 and over | Adult | Female | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Care and treatment | Chemotherapy | Radiation | Development and progression | Metastasis | Lung cancer, Non-small cell | Cancer | Analysis | Index Medicus
Journal Article
Head & neck oncology, ISSN 1758-3284, 2010, Volume 2, Issue 1, pp. 15 - 15
Life Sciences & Biomedicine | Oncology | Science & Technology | Head and Neck Neoplasms - virology | Carcinoma, Squamous Cell - epidemiology | Carcinoma, Squamous Cell - pathology | Carcinoma, Squamous Cell - virology | Humans | Middle Aged | Papillomavirus Infections - epidemiology | Risk Factors | Male | Survival Rate | Papillomaviridae - isolation & purification | Head and Neck Neoplasms - pathology | Papillomavirus Infections - pathology | Carcinoma, Squamous Cell - mortality | Head and Neck Neoplasms - epidemiology | Female | Head and Neck Neoplasms - mortality | Complications and side effects | Squamous cell carcinoma | Genetic aspects | Research | Diagnosis | Gene expression | Papillomavirus infections | Risk factors | Index Medicus
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 04/2009, Volume 27, Issue 12, pp. 2081 - 2090
Life Sciences & Biomedicine | Oncology | Science & Technology | Tumors of the respiratory system and mediastinum | Biological and medical sciences | Medical sciences | Tumors | Pneumology | Pleural Effusion, Malignant - therapy | Mesothelioma - therapy | Mesothelioma - diagnosis | Humans | Pleural Effusion, Malignant - diagnosis | Index Medicus | ROM | Thor17 | Review | Thor13 | Thor14
Journal Article
The lancet oncology, ISSN 1470-2045, 2015, Volume 16, Issue 4, pp. 447 - 456
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Lung Neoplasms - drug therapy | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Double-Blind Method | Mesothelioma - pathology | Humans | Hydroxamic Acids - adverse effects | Middle Aged | Kaplan-Meier Estimate | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Neoplasm Recurrence, Local - drug therapy | Lung Neoplasms - pathology | Male | Mesothelioma - drug therapy | Neoplasm Recurrence, Local - pathology | Drug-Related Side Effects and Adverse Reactions | Vorinostat | Aged, 80 and over | Hydroxamic Acids - administration & dosage | Placebos | Adult | Female | Aged | Mesothelioma, Malignant | Neoplasm Staging | Medical colleges | Care and treatment | Chemotherapy | Clinical trials | Mesothelioma | Gene expression | Cancer | Index Medicus | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Cancer and Oncology | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
The lancet oncology, ISSN 1470-2045, 09/2017, Volume 18, Issue 9, pp. 1261 - 1273
Life Sciences & Biomedicine | Oncology | Science & Technology | Lung Neoplasms - drug therapy | Double-Blind Method | Mesothelioma - pathology | Lung Neoplasms - mortality | Humans | Middle Aged | Antibodies, Monoclonal - therapeutic use | Lung Neoplasms - pathology | Male | Mesothelioma - mortality | Response Evaluation Criteria in Solid Tumors | Survival Rate | Treatment Outcome | Antineoplastic Agents - therapeutic use | Mesothelioma - drug therapy | Antibodies, Monoclonal, Humanized | Disease-Free Survival | Female | Aged | Mesothelioma, Malignant | Monoclonal antibodies | Clinical trials | Mesothelioma | Index Medicus
Journal Article
Nature communications, ISSN 2041-1723, 08/2020, Volume 11, Issue 1, pp. 4254 - 4254
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Respiratory function | Transcription | Stabilization | Lung diseases | Thioredoxin | Proteins | Signaling | Bleomycin | Pulmonary fibrosis | Lungs | Fibrosis | Fibroblasts | Deletion | Protein disulfide-isomerase | Endoplasmic reticulum | Public health | Index Medicus
Journal Article
2011, Corpus and discourse, ISBN 9781441159960, xxxiv, 268
Book
Molecular cancer, ISSN 1476-4598, 10/2013, Volume 12, Issue 1, pp. 128 - 128
Nasopharyngeal carcinoma | Senescence | Hsp90 inhibitor | AT13387 | Antitumor | Biochemistry & Molecular Biology | Oncology | Life Sciences & Biomedicine | Science & Technology | Nasopharyngeal Neoplasms - metabolism | Carcinoma | Neoplastic Stem Cells - drug effects | Humans | Nasopharyngeal Neoplasms - virology | Cellular Senescence - drug effects | Nasopharyngeal Neoplasms - pathology | SOXB1 Transcription Factors - metabolism | Tubulin - metabolism | Neoplastic Stem Cells - metabolism | Hyaluronan Receptors - metabolism | Female | Antineoplastic Agents - pharmacology | Benzamides - pharmacology | Spheroids, Cellular - drug effects | Acetylation | Nasopharyngeal Neoplasms - drug therapy | Protein Stability | Isoindoles - pharmacology | Cell Survival - drug effects | Nasopharyngeal Carcinoma | Histone Deacetylase 6 | Spheroids, Cellular - metabolism | Histone Deacetylases - metabolism | Epstein-Barr Virus Infections - drug therapy | Epstein-Barr Virus Infections - pathology | Xenograft Model Antitumor Assays | Animals | Tumor Burden - drug effects | HSP90 Heat-Shock Proteins - antagonists & inhibitors | Mice, Nude | Cell Line, Tumor | HSP90 Heat-Shock Proteins - metabolism | Cell Proliferation - drug effects | Mice | Mice, Inbred BALB C | Protein Processing, Post-Translational | Epstein-Barr Virus Infections - metabolism | Analysis | Stem cells | Heat shock proteins | Epstein-Barr virus | Antitussive agents | Nasopharyngeal cancer | Tubulins | Index Medicus
Journal Article
Global ecology and biogeography, ISSN 1466-822X, 7/2010, Volume 19, Issue 4, pp. 504 - 514
Datasets | Lyme disease | Ecological modeling | Disease models | Ticks | Medical entomology | Disease risk | Modeling | Nymphs | Altitude | Borrelia burgdorferi | USA | remote sensing | climate | tick‐borne | Ixodes scapularis | Tick-borne | Climate | Remote sensing | Physical Sciences | Life Sciences & Biomedicine | Physical Geography | Geography, Physical | Environmental Sciences & Ecology | Ecology | Science & Technology | Fundamental and applied biological sciences. Psychology | General aspects | Synecology | Teledetection and vegetation maps | Animal, plant and microbial ecology | General aspects. Techniques | Biological and medical sciences | Animal and plant ecology | Weather | Medical research | Analysis | Phytochemistry | Medicine, Experimental | Meteorological stations | Universities and colleges | Health aspects | Public health | Anaplasmosis | Life Sciences
Journal Article
CA: a cancer journal for clinicians, ISSN 0007-9235, 09/2019, Volume 69, Issue 5, pp. 402 - 429
BRCA1‐associated protein 1 (BAP1) | gene‐environment interaction | asbestos | chromothripsis | immunotherapy | cancer syndromes | mesothelioma | Life Sciences & Biomedicine | Oncology | Science & Technology | United States - epidemiology | Pleura - drug effects | Prognosis | Carcinogenesis - chemically induced | Humans | Pleural Neoplasms - diagnosis | Incidence | Global Burden of Disease | Diagnostic Errors | Tumor Suppressor Proteins - genetics | Biomarkers, Tumor - metabolism | Germ-Line Mutation | Inhalation Exposure - adverse effects | Ubiquitin Thiolesterase - metabolism | Molecular Targeted Therapy - methods | Pleural Neoplasms - epidemiology | Genetic Predisposition to Disease | Mesothelioma - therapy | Tumor Suppressor Proteins - metabolism | Biomarkers, Tumor - analysis | Occupational Exposure - adverse effects | Carcinogenesis - genetics | Europe - epidemiology | International Cooperation | Mesothelioma - diagnosis | Pleura - surgery | Ubiquitin Thiolesterase - genetics | Pleural Neoplasms - therapy | Australia - epidemiology | Pleural Neoplasms - etiology | Carcinogenesis - pathology | Pneumonectomy - methods | Antineoplastic Agents, Immunological - therapeutic use | Pleura - pathology | Asbestos - adverse effects | Mesothelioma - epidemiology | Biomarkers, Tumor - genetics | Combined Modality Therapy - methods | Mesothelioma - etiology | Asbestos | Molecular modelling | Immune response | BRCA1 protein | Surgery | Mesothelioma | Diagnosis | Epidemiology | Developing countries--LDCs | Peritoneum | Index Medicus | Abridged Index Medicus
Journal Article